Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults
Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against [...]
4 events found.
ISV Webinar Series
Computational Modelling of Vaccine Responses
Speaker: Tal Einav, LaJolla Institute of Immunology, United States Time: [...]
Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotic use
Title: Estimating the impact of vaccines in reducing antimicrobial resistance [...]
ISV July Webinar Series
Title: TBC Speaker: Don Diamond, City of Hope, United States [...]